Delivery Order SPE2DB22D2214-SPE2DB26FS2MK
- Not listed
- The Defense Logistics Agency awarded a $2,720.90 delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pens on September 3, 2025, with an ultimate completion date of September 4, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $11,046.77 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pens on September 3, 2025, with completion scheduled for September 4, 2025. This contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens in 0.5 ml quantities, valued at $28,003.89. This firm fixed-price delivery order, with an ultimate completion date of October 22, 2025, carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under the company's...
- The Defense Logistics Agency awarded a $7,754.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This is a non-set-aside competitive award with an ultimate completion date of October 27, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply contract vehicle. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens valued at $1,632.54 with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under the company's existing contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $2,618.19 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pens on April 24, 2025, with completion expected by April 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The award represents a single transaction under AmerisourceBergen's broader federal contracting relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $2,448.81 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on August 18, 2025, with completion scheduled for August 19, 2025. This contract was awarded on a firm fixed-price basis without set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens with a ceiling value of $26,411.84. This firm fixed price delivery order represents a non-competitive award and is scheduled for completion by September 29, 2025. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens valued at $1,904.63 with a completion date of June 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded transaction for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $19,487.23 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens with a completion date of September 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and represents a single delivery transaction under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB26FS2MKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens valued at $2,313.04, with completion scheduled for October 27, 2025. This non-competitive, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a diverse range of medications, vaccines, and medical supplies to support military healthcare programs and other federal medical systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen maintains a significant role in the federal medical supply chain, consistently fulfilling delivery orders for specialty medications and critical medical commodities across multiple therapeutic domains to support Department of Defense and veteran healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 10/24/25 |